SCHEMBL7733889

SCHEMBL7733889

CC1(C)O[C@@H]2[C@H](O1)[C@@H](CO)O[C@H]2n1cnc2c(NC3CCOCC3)ncnc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 1/20 0.64
PI4K2B Q8TCG2 1/20 0.64
PI4K2A Q9BTU6 1/20 0.64
PI4KB Q9UBF8 1/20 0.64
ADORA3 P0DMS8 5/20 0.63
ADORA1 P30542 4/20 0.63
ADORA2A P29274 4/20 0.63
ADORA2B P29275 3/20 0.63
SLC29A1 Q99808 2/20 0.63
SLC28A1 O00337 1/20 0.63
TSHR P16473 3/20 0.59
PMP22 Q01453 2/20 0.59
GAA P10253 1/20 0.59
HTT P42858 1/20 0.59
SIGMAR1 Q99720 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
TP53 P04637 1/20 0.59
NFKB1 P19838 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13384988 0.95 ADORA1 (0.71) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL4649323 0.94 PI4KA (0.68) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL12200089 0.93 ADORA3 (0.69) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL15144301 0.93 ADORA3 (0.69) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL5507191 0.93 ADORA3 (0.69) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL7735031 0.93 ADORA3 (0.69) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL5508361 0.92 TSHR (0.70) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL5993960 0.90 ADORA3 (0.64) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL15425648 0.88 PI4KA (0.62) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL15426679 0.88 PI4KA (0.62) PI4KAPI4K2BPI4K2API4KBADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407076-B1 ANTIISCHEMIC, ANTILIPOLYTIC, ANTICONVULSANT AND HYPOTENSIVE AGENTS; CARDIOVASCULAR AND NERVOUS SYSTEM DISORDERS; ATHEROSCLEROSIS SMITHKLINE BEECHAM CORPORATION 2002-06-18 US disclosed
EP-1027363-A2 ADENOSINE A1-RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2000-08-16 EP disclosed
WO-1999024450-A2 ADENSINE A1 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 1999-05-20 WO disclosed